Related Experiment Videos
The prevalence of multiple sclerosis in New Zealand
Acta Neurologica Scandinavica
|January 1, 1971
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The natural history of multiple sclerosis: a regional study with some longitudinal data.
Journal of neurology, neurosurgery, and psychiatry·1992
Class II HLA antigens in multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry·1989
Comparison of mefenamic acid and propranolol with placebo in migraine prophylaxis.
Acta neurologica Scandinavica·1986
Ethnic and HLA patterns related to multiple sclerosis in Wellington, New Zealand.
Journal of neurology, neurosurgery, and psychiatry·1986
Gliomatosis cerebri--report of a case.
Pathology·1985
Studies of endemic cretinism in Papua New Guinea: digital and palmar dermatoglyphic patterns.
American journal of physical anthropology·1983
Advances in sudden unexpected death in epilepsy.
Acta neurologica Scandinavica·2022
Non-convulsive seizures and non-convulsive status epilepticus in neuro-intensive care unit.
Acta neurologica Scandinavica·2022
Positron emission tomography in autoimmune encephalitis: Clinical implications and future directions.
Acta neurologica Scandinavica·2022
Seizure detection based on wearable devices: A review of device, mechanism, and algorithm.
Acta neurologica Scandinavica·2022
Walking confidence and perceived locomotion ability explain participation after stroke: A cross-sectional experimental study.
Acta neurologica Scandinavica·2022
Clinical features of Guillain-Barré syndrome with anti-neurofascin 155 antibody.
Acta neurologica Scandinavica·2022
Machine-Vision-Authenticated Hue-Programmable Bilayer Heterostructures for Anticounterfeiting.
ACS applied materials & interfaces·2026
Sub-stoichiometric 5-methoxyuridine modification enables tunable immune evasion and protein expression from synthetic mRNAs.
Molecular therapy. Nucleic acids·2026
Size-dependent surface engineering of magnetic micro/nanorobots for synergistic chemo-magnetothermal cancer therapy.
Chemical communications (Cambridge, England)·2026